Literature DB >> 27668760

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.

F Saraceni1, B Bruno2, R M Lemoli3, G Meloni4, W Arcese5, M Falda6, F Ciceri7, E P Alessandrino8, G Specchia9, R Scimè10, R Raimondi11, A Bacigalupo12, A Bosi13, F Onida14, A Rambaldi15, F Bonifazi3, A Olivieri1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27668760     DOI： 10.1038/bmt.2016.233

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.

Authors:  Edo Vellenga; Wim van Putten; Gert J Ossenkoppele; Leo F Verdonck; Matthias Theobald; Jan J Cornelissen; Peter C Huijgens; Johan Maertens; Alois Gratwohl; Ron Schaafsma; Urs Schanz; Carlos Graux; Harry C Schouten; Augustin Ferrant; Mario Bargetzi; Martin F Fey; Bob Löwenberg
Journal:  Blood       Date:  2011-09-27       Impact factor: 22.113

2.  T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Simona Piemontese; William Arcese; Stella Santarone; He Huang; Giovanna Meloni; Felicetto Ferrara; Dietrich Beelen; Miguel Sanz; Andrea Bacigalupo; Fabio Ciceri; Audrey Mailhol; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

3.  Impact of FLT3 ITD/NPM1 mutation status in adult patients with acute myelocytic leukemia autografted in first remission.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Giovanna Meloni; Arnaud Pigneux; Jordi Esteve; Mohty Mohamad
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

4.  Autologous bone-marrow transplantation in acute myelocytic leukaemia.

Authors:  N C Gorin; A Najman; G Duhamel
Journal:  Lancet       Date:  1977-05-14       Impact factor: 79.321

5.  Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Didier Blaise; Josy Reiffers; Giovanna Meloni; Mauricette Michallet; Theo de Witte; Michel Attal; Bernard Rio; Francois Witz; Loic Fouillard; Roel Willemze; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

6.  Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.

Authors:  Armand Keating; Gisela DaSilva; Waleska S Pérez; Vikas Gupta; Corey S Cutler; Karen K Ballen; Mitchell S Cairo; Bruce M Camitta; Richard E Champlin; James L Gajewski; Hillard M Lazarus; Michael Lill; David I Marks; Chadi Nabhan; Gary J Schiller; Gerald Socie; Jeffrey Szer; Martin S Tallman; Daniel J Weisdorf
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

7.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

8.  Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Francesco Frassoni; Noel Milpied; Michel Attal; Didier Blaise; Giovanna Meloni; Anna P Iori; Mauricette Michallet; Roel Willemze; Eric Deconninck; Jean-Luc Harousseau; Emmanuelle Polge; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

9.  Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.

Authors:  M Mizutani; M Hara; H Fujita; J Aoki; H Kanamori; K Ohashi; K Usuki; T Fukuda; T Chou; J Tanaka; Y Atsuta; A Takami
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

10.  Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.

Authors:  Dorle Messerer; Jutta Engel; Joerg Hasford; Markus Schaich; Gerhard Ehninger; Cristina Sauerland; Thomas Büchner; Andrea Schumacher; Rainer Krahl; Dietger Niederwieser; Jürgen Krauter; Arnold Ganser; Ursula Creutzig; Hartmut Döhner; Richard F Schlenk
Journal:  Haematologica       Date:  2008-05-10       Impact factor: 9.941
View more
  4 in total

1.  Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.

Authors:  Toshihiro Miyamoto; Koji Nagafuji; Tomoaki Fujisaki; Naoyuki Uchida; Kosei Matsue; Hideho Henzan; Ryosuke Ogawa; Ken Takase; Takatoshi Aoki; Michihiro Hidaka; Takanori Teshima; Shuichi Taniguchi; Koichi Akashi; Mine Harada
Journal:  Int J Hematol       Date:  2017-12-14       Impact factor: 2.490

Review 2.  Autologous Transplantation for Older Adults with AML.

Authors:  Beatrice U Mueller; Katja Seipel; Ulrike Bacher; Thomas Pabst
Journal:  Cancers (Basel)       Date:  2018-09-19       Impact factor: 6.639

3.  Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy.

Authors:  Zeynep Arzu Yegin; Asena Dikyar; Lale Aydın Kaynar; Ferda Can; Zübeyde Nur Özkurt; Münci Yağcı
Journal:  Hematol Rep       Date:  2020-12-02

4.  Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.

Authors:  Sijian Yu; Zhiping Fan; Liping Ma; Yu Wang; Fen Huang; Qing Zhang; Jiafu Huang; Shunqing Wang; Na Xu; Li Xuan; Mujun Xiong; Lijie Han; Zhiqiang Sun; Hongyu Zhang; Hui Liu; Guopan Yu; Pengcheng Shi; Jun Xu; Meiqing Wu; Ziwen Guo; Yiying Xiong; Chongyang Duan; Jing Sun; Qifa Liu; Yu Zhang
Journal:  JAMA Netw Open       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.